Aft Pharmaceuticals logo
AFP
Pharmaceuticals, Biotechnology & Life Sciences

Aft Pharmaceuticals

Short interest
0.00%
0.00 pp 30d
as of 6 Aug 2021
Reported shorts
667
Shares on issue
104.679M

Aft Pharmaceuticals (AFP) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
29 July

What Puts AFT (ASX:AFP) on Smallcap Radars?

Highlights A: FT Pharmaceuticals is drawing attention as portfolio expansion keeping smaller healthcare names in view. Today's ASX tone is shaped by smallcap healthcare is being filtered for evidence and commercial discipline. The key question is whether smaller healthcare names can prove durability in a cautious market. A: ustralia's sharemarket has opened with a firmer pulse, and Cyclopharm (ASX:CYC), a nuclear medicine company known for its Technegas lung imaging product, is helping frame ...

Kalkine
Positive
21 May

AFT Pharmaceuticals Profit Surges As Global Expansion Gains Momentum

Highlights AFT Pharmaceuticals reported strong profit growth supported by rising revenue. Expansion across international healthcare markets continued gaining traction. Management expects further earnings and sales momentum during the current financial year. AFT Pharmaceuticals Ltd (ASX:AFP) shares moved higher after the healthcare company delivered a strong full-year result driven by expanding sales across both Australasian and international operations. The company highlighted broad-based gro...